
Genetron Holdings Limited GTH
Geschäftsbericht 2022
hinzugefügt 21.12.2024
Genetron Holdings Limited Betriebszyklus 2011-2025 | GTH
Betriebszyklus Jährlich Genetron Holdings Limited
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | 185 | - | - | - | - | - | - |
Alle Zahlen in CNY-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 185 | 185 | 185 |
Betriebszyklus anderer Aktien in der Diagnostik & Forschung
| Name | Betriebszyklus | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M | ||
|
DarioHealth Corp.
DRIO
|
251 | $ 12.15 | 2.14 % | $ 345 M | ||
|
DexCom
DXCM
|
204 | $ 66.06 | -1.34 % | $ 25.5 B | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Exact Sciences Corporation
EXAS
|
269 | $ 101.57 | 0.07 % | $ 18.8 B | ||
|
Burning Rock Biotech Limited
BNR
|
275 | $ 16.0 | 1.59 % | $ 172 M | ||
|
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
329 | $ 1.56 | -3.7 % | $ 1.98 M | ||
|
Castle Biosciences
CSTL
|
97.9 | $ 38.95 | 0.82 % | $ 1.08 B | ||
|
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | ||
|
Danaher Corporation
DHR
|
150 | $ 227.29 | 0.42 % | $ 166 B | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 26.94 | -0.74 % | $ 815 M | ||
|
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | ||
|
Mettler-Toledo International
MTD
|
63.7 | $ 1 408.65 | 1.08 % | $ 29.9 B | ||
|
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B | ||
|
NeoGenomics
NEO
|
103 | $ 12.15 | 2.53 % | $ 1.54 B | ||
|
Neogen Corporation
NEOG
|
213 | $ 6.84 | -0.36 % | $ 1.48 B | ||
|
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
76.4 | $ 19.9 | -3.21 % | $ 1.07 B | ||
|
Pacific Biosciences of California
PACB
|
183 | $ 2.12 | - | $ 538 M | ||
|
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | ||
|
Anixa Biosciences
ANIX
|
385 | $ 3.35 | -6.42 % | $ 107 K | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 26.46 | -0.62 % | $ 20 B | ||
|
Co-Diagnostics
CODX
|
405 | $ 0.3 | -13.39 % | $ 8.8 M | ||
|
Precipio
PRPO
|
49.8 | $ 24.67 | -1.2 % | $ 32 M | ||
|
Quidel Corporation
QDEL
|
68.4 | $ 28.82 | 0.07 % | $ 1.21 B | ||
|
IQVIA Holdings
IQV
|
78 | $ 224.13 | 0.84 % | $ 40.6 B | ||
|
QIAGEN N.V.
QGEN
|
172 | $ 45.14 | -0.21 % | $ 10 B | ||
|
Guardant Health
GH
|
49.1 | $ 103.55 | 1.45 % | $ 12.7 B | ||
|
Aspira Women's Health
AWH
|
73.8 | - | -6.19 % | $ 10.5 M | ||
|
Sotera Health Company
SHC
|
83.5 | $ 16.76 | -0.42 % | $ 4.74 B | ||
|
Soleno Therapeutics
SLNO
|
193 | $ 49.79 | -4.25 % | $ 2 B | ||
|
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | ||
|
Thermo Fisher Scientific
TMO
|
69.8 | $ 574.27 | 0.46 % | $ 219 B | ||
|
Illumina
ILMN
|
198 | $ 134.66 | -0.16 % | $ 21.4 B | ||
|
Charles River Laboratories International
CRL
|
67.7 | $ 197.59 | 2.36 % | $ 10.2 B | ||
|
Trinity Biotech plc
TRIB
|
299 | $ 0.96 | -10.6 % | $ 61.9 M | ||
|
Twist Bioscience Corporation
TWST
|
96.1 | $ 31.39 | 1.47 % | $ 1.88 B | ||
|
Quotient Limited
QTNT
|
432 | - | -11.32 % | $ 1.1 M | ||
|
Quest Diagnostics Incorporated
DGX
|
56.9 | $ 184.04 | 0.81 % | $ 20.4 B | ||
|
Biodesix
BDSX
|
41.7 | $ 7.63 | -2.8 % | $ 989 M | ||
|
Myriad Genetics
MYGN
|
87.1 | $ 7.07 | -2.01 % | $ 641 M |